Ecor1 Capital Fund Qualified, L.p. - Net Worth and Insider Trading

Ecor1 Capital Fund Qualified, L.p. Net Worth

The estimated net worth of Ecor1 Capital Fund Qualified, L.p. is at least $87 Million dollars as of 2024-04-28. Ecor1 Capital Fund Qualified, L.p. is the 10% Owner of Kura Oncology Inc and owns about 4,408,097 shares of Kura Oncology Inc (KURA) stock worth over $87 Million. Ecor1 Capital Fund Qualified, L.p. is also the 10% Owner of aTyr Pharma Inc and owns about 0 shares of aTyr Pharma Inc (LIFE) stock worth over $0. Details can be seen in Ecor1 Capital Fund Qualified, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ecor1 Capital Fund Qualified, L.p. has not made any transactions after 2018-12-21 and currently still holds the listed stock(s).

Transaction Summary of Ecor1 Capital Fund Qualified, L.p.

To

Ecor1 Capital Fund Qualified, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ecor1 Capital Fund Qualified, L.p. owns 7 companies in total, including Panacea Acquisition Corp (PANA.U) , Kura Oncology Inc (KURA) , and aTyr Pharma Inc (LIFE) among others .

Click here to see the complete history of Ecor1 Capital Fund Qualified, L.p.’s form 4 insider trades.

Insider Ownership Summary of Ecor1 Capital Fund Qualified, L.p.

Ticker Comapny Transaction Date Type of Owner
PANA.U Panacea Acquisition Corp 2020-07-06 director & 10 percent owner
KURA Kura Oncology Inc 2018-12-21 10 percent owner
LIFE aTyr Pharma Inc 2018-05-16 10 percent owner
ASMB Assembly Biosciences Inc 2016-06-20 10 percent owner
GNVC Genvec Inc 2014-05-22 other: See Explanation of Responses
NUVB Nuvation Bio Inc 2023-02-19 director
PANA Panacea Acquisition Corp II 2023-04-28 director & 10 percent owner

Ecor1 Capital Fund Qualified, L.p. Latest Holdings Summary

Ecor1 Capital Fund Qualified, L.p. currently owns a total of 2 stocks. Among these stocks, Ecor1 Capital Fund Qualified, L.p. owns 4,408,097 shares of Kura Oncology Inc (KURA) as of December 21, 2018, with a value of $87 Million and a weighting of 100%. Ecor1 Capital Fund Qualified, L.p. also owns 0 shares of aTyr Pharma Inc (LIFE) as of May 16, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Ecor1 Capital Fund Qualified, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KURA Kura Oncology Inc 2018-12-21 4,408,097 19.65 86,619,106
LIFE aTyr Pharma Inc 2018-05-16 0 1.57 0

Holding Weightings of Ecor1 Capital Fund Qualified, L.p.


Ecor1 Capital Fund Qualified, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Ecor1 Capital Fund Qualified, L.p. has made a total of 0 transactions in Kura Oncology Inc (KURA) over the past 5 years. The most-recent trade in Kura Oncology Inc is the acquisition of 213,888 shares on December 21, 2018, which cost Ecor1 Capital Fund Qualified, L.p. around $3 Million.

According to the SEC Form 4 filings, Ecor1 Capital Fund Qualified, L.p. has made a total of 0 transactions in aTyr Pharma Inc (LIFE) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the sale of 229,238 shares on May 16, 2018, which brought Ecor1 Capital Fund Qualified, L.p. around $3 Million.

Insider Trading History of Ecor1 Capital Fund Qualified, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ecor1 Capital Fund Qualified, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Ecor1 Capital Fund Qualified, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ecor1 Capital Fund Qualified, L.p. is 11.66%. GuruFocus also compares Ecor1 Capital Fund Qualified, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Ecor1 Capital Fund Qualified, L.p. within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ecor1 Capital Fund Qualified, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ecor1 Capital Fund Qualified, L.p.

Average Return

9.68%

Average return per transaction

Outperforming Transactions

100%

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.34 11.66 33.79 9.68 68.21 -0.06
Relative Return to S&P 500(%) 16.55 2.66 21.57 -13.5 48.75 -21.56

Ecor1 Capital Fund Qualified, L.p. Ownership Network

Ownership Network List of Ecor1 Capital Fund Qualified, L.p.

No Data

Ownership Network Relation of Ecor1 Capital Fund Qualified, L.p.


Ecor1 Capital Fund Qualified, L.p. Owned Company Details

What does Panacea Acquisition Corp do?

Who are the key executives at Panacea Acquisition Corp?

Ecor1 Capital Fund Qualified, L.p. is the director & 10 percent owner of Panacea Acquisition Corp. Other key executives at Panacea Acquisition Corp include director & 10 percent owner Ecor1 Capital, Llc , director & CEO and Chairman of the Board Oleg Nodelman , and director & 10 percent owner Ecor1 Capital Fund, L.p. .

Panacea Acquisition Corp (PANA.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Panacea Acquisition Corp (PANA.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Acquisition Corp (PANA.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Panacea Acquisition Corp (PANA.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Panacea Acquisition Corp Insider Transactions

No Available Data

Ecor1 Capital Fund Qualified, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Ecor1 Capital Fund Qualified, L.p.. You might contact Ecor1 Capital Fund Qualified, L.p. via mailing address: 357 Tehama Street #3, San Francisco Ca 94103.

Discussions on Ecor1 Capital Fund Qualified, L.p.

No discussions yet.